GlassScriptPhysician profile
Helen Manalis
NPI 1295712347
$4,370.22
in general payments reported to CMS, 2019-2025
38 companies · $1,545 in 2025
The $1,545 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,085 · 2020: $873 · 2022: $39.24 · 2023: $254 · 2024: $574 · 2025: $1,545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,373.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $703.10 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $517.32 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $396.36 | 2019-2025 | |
| Lilly USA, LLC | $290.89 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Astellas Pharma US INC | $284.30 | 2019-2025 | Veozah |
| Glaxosmithkline, LLC. | $261.67 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Kowa Pharmaceuticals America, INC. | $235.12 | 2019-2025 | Zoryve, Livalo, Seglentis |
| Merck Sharp & Dohme LLC | $188.49 | 2019-2020 | |
| Abbvie INC. | $167.58 | 2020-2025 | |
| Exact Sciences Corporation | $148.24 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $93.50 | 2019-2020 | |
| Daiichi Sankyo INC. | $85.10 | 2019-2020 | |
| Sanofi Pasteur INC. | $84.61 | 2019-2024 | |
| Amgen INC. | $82.94 | 2019-2020 | |
| Bausch Health US, LLC | $77.59 | 2019-2024 | Aplenzin, Wellbutrin |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Manalis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.